SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Evelien L. Smits, Viggo F. Van Tendeloo, Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials, Pharmacology & Therapeutics, 2016, 158, 24

    CrossRef

  2. 2
    Telma Palomo, Maria C. Andrade, Barbara S. E. Peters, Fernanda A. Reis, João Tomás A. Carvalhaes, Francis H. Glorieux, Frank Rauch, Marise Lazaretti-Castro, Evaluation of a Modified Pamidronate Protocol for the Treatment of Osteogenesis Imperfecta, Calcified Tissue International, 2016, 98, 1, 42

    CrossRef

  3. 3
    Gillian M. Keating, Ibandronate: A Review in Japanese Patients with Osteoporosis, Drugs & Aging, 2016, 33, 4, 295

    CrossRef

  4. 4
    F. Vescini, R. Attanasio, A. Balestrieri, F. Bandeira, S. Bonadonna, V. Camozzi, S. Cassibba, R. Cesareo, I. Chiodini, C. Maria Francucci, L. Gianotti, F. Grimaldi, R. Guglielmi, B. Madeo, C. Marcocci, A. Palermo, A. Scillitani, E. Vignali, V. Rochira, M. Zini, Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis, Journal of Endocrinological Investigation, 2016,

    CrossRef

  5. You have free access to this content5
    Robert A Adler, Ghada El-Hajj Fuleihan, Douglas C Bauer, Pauline M Camacho, Bart L Clarke, Gregory A Clines, Juliet E Compston, Matthew T Drake, Beatrice J Edwards, Murray J Favus, Susan L Greenspan, Ross McKinney, Robert J Pignolo, Deborah E Sellmeyer, Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research, 2016, 31, 1
  6. 6
    R. Eastell, D.-J. Dijk, M. Small, A. Greenwood, J. Sharpe, H. Yamada, M. Yuba, M. Tanimoto, S. Deacon, Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial, Osteoporosis International, 2016, 27, 1, 309

    CrossRef

  7. 7
    Vrinda Saraff, Wolfgang Högler, ENDOCRINOLOGY AND ADOLESCENCE: Osteoporosis in children: diagnosis and management, European Journal of Endocrinology, 2015, 173, 6, R185

    CrossRef

  8. 8
    V. Fadda, D. Maratea, S. Trippoli, A. Messori, Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference, Journal of Endocrinological Investigation, 2015, 38, 2, 189

    CrossRef

  9. 9
    Susan M. Ott, Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease, Seminars in Dialysis, 2015, 28, 4
  10. 10
    Aarati Khanal, Gregory M. Peterson, Ronald L. Castelino, Matthew D. Jose, Potentially Inappropriate Prescribing of Renally Cleared Drugs in Elderly Patients in Community and Aged Care Settings, Drugs & Aging, 2015, 32, 5, 391

    CrossRef

  11. 11
    Heather A. Nyman, Renal Dosing in High-Risk Populations, Journal of Infusion Nursing, 2015, 38, 3, 210

    CrossRef

  12. 12
    Lydia G. Schipper, Hanneke W. H. A. Fleuren, Joop P. W. van den Bergh, Johan R. Meinardi, Bart A. J. Veldman, Cornelis Kramers, Treatment of osteoporosis in renal insufficiency, Clinical Rheumatology, 2015, 34, 8, 1341

    CrossRef

  13. 13
    F. Jakob, L. Seefried, M. Schwab, Alter und Osteoporose, Der Internist, 2014, 55, 7, 755

    CrossRef

  14. 14
    Paul D. Miller, Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management, American Journal of Kidney Diseases, 2014, 64, 2, 290

    CrossRef

  15. 15
    Paul D Miller, Chronic kidney disease and osteoporosis: evaluation and management, BoneKEy Reports, 2014, 3,

    CrossRef

  16. 16
    Paul D Miller, Chronic kidney disease and the skeleton, Bone Research, 2014, 2, 14044

    CrossRef

  17. 17
    Paul D Miller, Long-term extension trials to prove the efficacy and safety of bisphosphonates, Clinical Investigation, 2014, 4, 1, 35

    CrossRef

  18. 18
    E. Michael Lewiecki, John P. Bilezikian, Lynda Bonewald, Juliet E. Compston, Robert P. Heaney, Douglas P. Kiel, Paul D. Miller, John T. Schousboe, Osteoporosis Update: Proceedings of the 2013 Santa Fe Bone Symposium, Journal of Clinical Densitometry, 2014, 17, 3, 330

    CrossRef

  19. 19
    Luigi Gennari, Daniela Merlotti, Domenico Rendina, Fernando Gianfrancesco, Teresa Esposito, Ranuccio Nuti, Paget’s disease of bone: epidemiology, pathogenesis and pharmacotherapy, Expert Opinion on Orphan Drugs, 2014, 2, 6, 591

    CrossRef

  20. 20
    R. Lubwama, A. Nguyen, A. Modi, C. Diana, P. D. Miller, Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: Is treatment with bisphosphonates an option?, Osteoporosis International, 2014, 25, 5, 1607

    CrossRef

  21. 21
    Freda Hannafon, Mary P. Cadogan, Recognition and Treatment of Postmenopausal Osteoporosis, Journal of Gerontological Nursing, 2014, 40, 3, 10

    CrossRef